Tumor mitochondria-targeted photodynamic therapy with a translocator protein (TSPO)-specific photosensitizer.
Ontology highlight
ABSTRACT: Photodynamic therapy (PDT) has been proven to be a minimally invasive and effective therapeutic strategy for cancer treatment. It can be used alone or as a complement to conventional cancer treatments, such as surgical debulking and chemotherapy. The mitochondrion is an attractive target for developing novel PDT agents, as it produces energy for cells and regulates apoptosis. Current strategy of mitochondria targeting is mainly focused on utilizing cationic photosensitizers that bind to the negatively charged mitochondria membrane. However, such an approach is lack of selectivity of tumor cells. To minimize the damage on healthy tissues and improve therapeutic efficacy, an alternative targeting strategy with high tumor specificity is in critical need. Herein, we report a tumor mitochondria
SUBMITTER: Zhang S
PROVIDER: S-EPMC4648641 | biostudies-literature | 2015 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA